Da32 Life Science Tech Acquisition Corp (DALS) Financials

$10.32

$0.00 (0.00%)

As on 04-Aug-2023 09:30EDT

Market cap

$264 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

171.7

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	1.84	1.76	0.37	--	--	--
Operating Profit (EBIT)	-1.84	-1.76	-0.60	--	--	--
Other Income	2.72	--	--	--	--	--
Profit before Tax	2.60	1.14	-0.57	--	--	--
Provision for Tax	0.73	0.54	-0.02	--	--	--
Profit after Tax (Net Income)	1.87	0.60	-0.55	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	1.49	--	-0.86	--	--	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	198.03	197.21	196.61	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.60	5.60	5.60	--	--	--
Current Liabilities	1.35	1.05	0.29	--	--	--
Total Liabilities	206.34	203.86	202.49	--	--	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	204.49	202.93	200.02	--	--	--
Current Assets	0.49	0.93	2.47	--	--	--
Total Assets	206.34	203.86	202.49	--	--	--
Total Debt*	--	--	--	--	--	--
Net Current Assets	-0.86	-0.12	2.18	--	--	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-1.10	-0.98	--	--	--
Cash Flow from Investing Activities	--	--	-300.00	--	--	--
Cash from Financing Activities	--	-0.07	202.85	--	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	0.37	0.12	--	--	--	--
Cash EPS ($)	--	0.12	--	--	--	--
Adjusted Book Value ($)	--	39.44	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.22	--	--	--	--
Free Cash Flow per Share ($)	--	-0.22	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	0.30	--	--	--	--
ROE (%)	0.95	0.30	--	--	--	--
ROA (%)	0.92	0.29	--	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	68.95	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-184.67	-195.33	--	--	--	--
Net Profit Growth (%)	-1,249.82	209.62	--	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	0.88	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	171.67	83.40	--	--	--	--
Price / Book Value	--	0.25	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-10.57	3.26	--	--	--
Close Price ($)	10.12	10.00	9.81	--	--	--
High Price ($)	11.00	10.61	10.26	--	--	--
Low Price ($)	9.61	9.58	9.65	--	--	--
Market Cap ($ Cr)	264.20	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	0.36	0.88	8.61	--	--	--
Quick Ratio	0.36	--	--	--	--	--
Interest Coverage	1.59	-0.61	-24.14	--	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.